by rdbiomed | Dec 4, 2017 | Company News
Maxhealth Medical Group, Peptest’s Chinese distributor, has presented the non-invasive device for diagnosing reflux to key opinion leaders at a China conference in November. The China Healthcare International Association, Gastroesophageal Reflux and Multidisciplinary...
by rdbiomed | Nov 13, 2017 | Company News
We’re pleased to announce that we have achieved the highly-coveted ISO 13485: 2016 certification. ISO 13485 is an internationally agreed standard specific to the medical devices industry. To achieve ISO 13485 certification, RD Biomed – the Hull-based medical...
by rdbiomed | Oct 27, 2017 | Company News
A three-month study into how Peptest can be used to diagnose gastro-oesophageal reflux disease has begun in China, following an official launch in August. The launch took place at the ‘Normal range reference of Chinese PGI research conference’ on 12 August 2017 at the...
by rdbiomed | Oct 20, 2017 | Company News
We’d like to introduce you to members of the RD Biomed and Peptest team… let’s meet Adrian. Versatile Adrian joined the company in April and provides administration support as well as help in the Peptest laboratories. Adrian explains: “My role is in...
by rdbiomed | Sep 25, 2017 | Company News
RD Biomed and the Peptest team headed to the OESO 14th World Conference (Global Perspective of Esophageal Disease) in Geneva in early September. OESO, with more than 14,000 members from 85 countries, is an international assembly of the world’s leading specialists who...
by rdbiomed | Aug 16, 2017 | Company News
We’re pleased to announce that we have officially registered Peptest – a device for the diagnosis of reflux disease – with the US Food and Drug Administration (FDA). Peptest is a non‑invasive, diagnostic medical device that contains antibodies for detecting the...
Recent Comments